Procyanidins: A promising anti‐diabetic agent with potential benefits on glucose metabolism and diabetes complications
Wound Repair and Regeneration · 2023-09 · 31 (5) · 688-699
DOI: 10.1111/wrr.13115 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Wound Repair and Regeneration, online erschienen am 30.08.2023. Verfasst von Eskandar Qaed und 9 weiteren Autor:innen. Beteiligte Einrichtung: Chemistry and Chemical Engineering Department, Lanzhou University, Gansu, China. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Proanthocyanidins, Diabetes Complications. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 96 Literaturangaben.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Diabetes mellitus (DM) is a complex disease with alarming worldwide health implications and high mortality rates, largely due to its complications such as cardiovascular disease, nephropathy, neuropathy, and retinopathy. Recent research has shown that procyanidins (PC), a type of flavonoid, have strong antioxidant and free radical elimination effects, and may be useful in improving glucose metabolism, enhancing pancreatic islet cell activity, and decreasing the prevalence of DM complications. This review article presents a systematic search for peer‐reviewed articles on the use of PC in the treatment of DM, without any language restrictions. The article also discusses the potential for PC to sensitise DM medications and improve their efficacy. Recent in vivo and in vitro studies have demonstrated promising results in improving the biological activity and bioavailability of PC for the treatment of DM. The article concludes by highlighting the potential for novel materials and targeted drug delivery methods to enhance the pharmacokinetics and bioactivity of PC, leading to the creation of safer and more effective anti‐DM medications in the future.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Chemistry and Chemical Engineering Department, Lanzhou University, Gansu, China.
- Department of Pharmacy, Faculty of Medicine and Health Sciences, University of Science and Technology, Aden, Yemen.
- School of Pharmacy & State Key Laboratory of Applied Organic Chemistry, Lanzhou University, Lanzhou, People's Republic of China.
- N.I. Pirogov Russian National Research Medical University, Moscow, Russia.
- Taiz University Faculty of Medicine and Health Science, Taizz, Yemen.
- The Key Laboratory of Neural and Vascular Biology, The Key Laboratory of New Drug Pharmacology and Toxicology, Department of Pharmacology, Ministry of Education, Hebei Medical University, Shijiazhuang, China.
ORCID-Profile: Eskandar Qaed, Zeyao Tang
Zitieren
APA
Qaed, E., Almoiliqy, M., Al-Hamyari, B., Qaid, A., Alademy, H., Al-Maamari, A., Alyafeai, E., Geng, Z., Tang, Z., & Ma, X. (2023). Procyanidins: A promising anti‐diabetic agent with potential benefits on glucose metabolism and diabetes complications. Wound Repair and Regeneration, 31(5), 688-699. https://doi.org/10.1111/wrr.13115
Vancouver
Qaed E, Almoiliqy M, Al-Hamyari B, Qaid A, Alademy H, Al-Maamari A, et al. Procyanidins: A promising anti‐diabetic agent with potential benefits on glucose metabolism and diabetes complications. Wound Repair and Regeneration. 2023;31(5):688-699. doi:10.1111/wrr.13115
BibTeX
@article{Qaed2023,
author = {Qaed, Eskandar and Almoiliqy, Marwan and Al-Hamyari, Bandar and Qaid, Abdullah and Alademy, Haneen and Al-Maamari, Ahmed and Alyafeai, Eman and Geng, Zhaohong and Tang, Zeyao and Ma, Xiaodong},
title = {Procyanidins: A promising anti‐diabetic agent with potential benefits on glucose metabolism and diabetes complications},
journal = {Wound Repair and Regeneration},
year = {2023},
volume = {31},
number = {5},
pages = {688--699},
doi = {10.1111/wrr.13115}
}
EUVIMED